Universities should not have to bow to research institutes, writes Debashis Gangopadhyay. Basic Sciences versus Applied Sciences Undermining humanities studies in schools will lead to a large number of science graduates in the market. This is a boon for multinational companies as profits will escalate — the cost of labour being lower. However, the danger to profits persist from another aspect. Students who study science out of their love for a subject are...

-The Hindu Journalists need to adopt a set of integrity measures in order to police the boundaries between the market and political power   Gina Rinehart, Australia’s richest person and the world’s wealthiest woman, is seeking three board seats following her purchase of 18.7 per cent of Fairfax which owns most papers in Australia not controlled by Rupert Murdoch’s News Ltd. There has already been considerable upheaval in two of the Fairfax papers...

Tuberculosis re-emerges as a major threat as new drug-resistant strains develop because of mismanagement of the disease. At the beginning of the year, doctors at Mumbai’s P.D. Hinduja National Hospital and Medical Research Centre reported that they had 12 patients infected with TDR-TB, or totally drug-resistant tuberculosis, a condition in which the TB bacilli is resistant to all first- and second-line drugs used in the conventional treatment of the disease. Panic...

-The United Nations Punitive laws and human rights abuses are costing lives, wasting money and stifling the global AIDS response, according to a report released today by a United Nations-backed commission.   Entitled HIV and the Law: Risks, Rights and Health, the report by the Global Commission on HIV and the Law – made up of former heads of state and leading legal, human rights and HIV experts, and supported by the UN...

-The Economic Times It's not just the drug regulator, where a parliamentary panel has alleged corruption, failing in its job. Drug regulation across entities that dot this broad landscape is in poor health and ineffective. In May, when a Parliamentary panel, during a routine examination of healthcare regulatory bodies, alleged corruption in the approval of new drugs, it was merely pointing out one symptom. Such symptoms pervade the entire drug regulation landscape,...